Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.79
+0.23 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Immunocore Holdings Revenue

In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth. Immunocore Holdings had revenue of $104.48M in the quarter ending December 31, 2025, with 24.30% growth.

Revenue (ttm)
$400.02M
Revenue Growth
+28.95%
P/S Ratio
3.66
Revenue / Employee
$763,389
Employees
524
Market Cap
1.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-4.63M-11.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Iovance Biotherapeutics 263.50M
Immatics 56.67M
Agios Pharmaceuticals 54.03M
Precigen 9.68M
Maze Therapeutics 2.50M
Oculis Holding AG 1.51M
Revenue Rankings

IMCR News

More News